Ricki Fairley, chief executive officer of Touch — The Black Breast Cancer Alliance, is urging immediate, sustained action to confront what she describes as a preventable public-health emergency in Black communities. Speaking broadly about chronic disease burdens, Fairley links higher rates of illness and death to a mix of environmental exposures, systemic neglect in medical care, generational trauma and a lack of science tailored to Black biology.
Numbers and risks
Fairley laid out a set of stark disparities in a post shared on LinkedIn and summarized from remarks she made at the National Urban League Convention. Her account cites several specific measures:
- 56% of Black adults have high blood pressure — described as the highest rate in the world.
- Black Americans are 35% more likely to die from cardiovascular disease and 50% more likely to suffer a stroke.
- Black adults are 60% more likely to be diagnosed with diabetes and face doubled rates of severe complications such as kidney failure and amputations.
- Up to 50% of Black individuals may carry elevated Lipoprotein(a), a genetic cardiovascular risk factor present from birth that is not responsive to diet, exercise or standard statin therapy.
- Across cancers, mortality rates are higher; for example, Black men are reported as more than twice as likely to die from prostate cancer, while Black women have a modestly lower incidence but higher mortality for breast cancer.
"If you were in the room with me at the National Urban League Convention for the Women of Power Luncheon in Nashville, you know I had just 4 short minutes on stage to deliver a message that requires a lifetime of urgency," Fairley wrote.
Roots of disparity and the call to act
Fairley frames these outcomes not as isolated clinical failures but as the product of accumulated disadvantage: differential environmental exposures, inequalities in access and quality of medical care, and research gaps that leave clinicians without evidence tailored to Black patients. She urges a multifaceted response that includes research, prevention, early detection and community-centered interventions.
Implications for research and public health
The emphasis on genetic risk factors such as elevated Lp(a) highlights a broader scientific challenge: not all drivers of disease are modifiable through lifestyle changes or current standard therapies. Where genetics contribute substantial risk, Fairley implies, public-health strategies must combine biomedical research with targeted screening and tailored clinical care. Equally, the disparities in outcomes for heart disease, stroke, diabetes and cancer suggest systemic fixes — from environmental policy to health-care access — will be necessary to close the gaps.
| Condition | Metric Cited |
|---|---|
| High blood pressure | 56% prevalence among Black adults |
| Cardiovascular death | 35% higher mortality |
| Stroke | 50% higher likelihood |
| Diabetes | 60% higher diagnosis rate |
| Lp(a) elevated | Up to 50% carry elevated levels |
Fairley’s remarks aim to move the conversation beyond awareness toward tangible, long-term commitments: investment in research that includes and targets Black populations, improved screening for hereditary risks, and policies that address social determinants of health. Her message to leaders and clinicians is one of urgency: the disparities are measurable and, she argues, largely preventable if addressed with focused science and sustained policy effort.
The account combines statistics with a moral and strategic appeal to prioritize a population-level response. Whether policymakers, funders and the research community will recalibrate priorities in response remains a central question raised by her call to action.
